NR4A1 and posterior cortical atrophy: This approach revealed potential therapeutic targets, p62 and SOX9, and identified signaling pathways downstream of inflammatory (e.g. IL-1 and TNF), FGF, or WNT signaling that could be targeted in both hormone receptor-independent, treatment-resistant BCa and PCa (Fig. 6).